Sponsors (4)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Provides specified, multiyear funding for the C.W. Bill Young Cell Transplantation Program by listing a $31,009,000 amount and authorizing $33,009,000 per year for fiscal years 2027–2031. Also directs a statutory revision to the cord blood inventory provision in the Stem Cell Therapeutic and Research Act, replacing the existing text with new language. Maintains and clarifies funding authorization for the federal cell transplantation program to support donor registries, cord blood inventory, and related activities; the bill replaces the current appropriation text with explicit yearly authorization amounts. The exact content of the new cord blood inventory language is not provided in the summary of changes, so operational impacts from that replacement are uncertain until the revised text is available.
The bill authorizes steady, increased funding to expand and stabilize the federal bone marrow and cord blood transplant program—improving patient access and provider planning—but it raises federal spending and still leaves actual year-to-year funding dependent on future appropriations.
Patients who need bone marrow or cord blood transplants (e.g., people with leukemia and other blood disorders) will see continued and increased federal funding for the C.W. Bill Young Cell Transplantation Program, improving program capacity and likely access to transplants from FY2027–2031.
Hospitals and transplant centers supporting the program gain multi-year authorized funding through FY2031, giving more predictable resources for planning and operations related to transplant services.
Maintaining and increasing appropriations supports staffing and training for transplant services, helping sustain workforce capacity and service quality at transplant centers.
Taxpayers face higher federal spending because the bill authorizes an additional $33,009,000 per year from FY2027–2031.
The statute authorizes funding but does not guarantee that Congress will appropriate the funds each year, so expected program expansion or sustained increases may not materialize for patients or providers.
Introduced March 17, 2026 by John F. Reed · Last progress March 17, 2026